ACE2 and COVID-19: Despite widespread speculation that hypertension (and especially drugs that inhibit RAS) would be associated with increased expression of ACE2 and that this in turn, lead to increased susceptibility to COVID-19, our study revealed no effect of either on the renal expression of ACE2.